Cyfuse and Cyberdyne Are Pushing the Boundaries of 3D Printed Human Engineering With Regenova

Imagine, if you will, a powerful robotic-limbed appliance with a human inside wrapped in 3D printed and cultured protective tissue. It’s capable of lifting enormous loads, and the human operator within can be repaired using the latest in bioprinting technology and materials.

It may well happen sooner than later, and a deal announced by a group of Japanese firms points the way forward.

Cyfuse Biomedical, the Japanese developers of a 3D printing process which can produce human tissue using a novel, robotic process, just raised 1.4 billion yen ($12 million USD) from investors who include robotic-human appliance developers, Cyberdyne Inc and a larger group of investors.

Cyfuse says they agreed to sell an undisclosed stake in their operations to a dozen Japanese investors, among them medical-device manufacturer Shibuya Kogyo Co. and health information provider M3 Inc.

Cyfuse is the developer of Regenova, a robotic-controlled 3D printer they created withShibuya Kogyo. The device turns living cell aggregates into artificial human tissue, and both companies say the tissue cultures will soon be used to test new products – and might eventually be used to construct human organs from an individual’s own stem cells. … (read more)

Source: 3Dprint.com